Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance

H. Mytrang(Memorial Sloan Kettering Cancer Center), Ming O. Li(Memorial Sloan Kettering Cancer Center), Chun Chou(Memorial Sloan Kettering Cancer Center), Alejo Efeyan(Spanish National Cancer Research Centre), Briana G. Nixon(Memorial Sloan Kettering Cancer Center), Min Peng(Children's Hospital of Philadelphia), Xinxin Wang(Memorial Sloan Kettering Cancer Center), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Xian Zhang(Xuzhou Medical College), Kristelle J. Capistrano(Memorial Sloan Kettering Cancer Center)
The Journal of Experimental Medicine
October 24, 2019
10.1084/jem.20190848
Cited by 47

Related Papers

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
mTOR signaling at a glance
|Journal of Cell Science|2009|2.1k
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
|The EMBO Journal|2012|1.9k
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
|Nature|2011|1.7k